These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 34294916

  • 1. Cellular senescence as a possible link between prostate diseases of the ageing male.
    Fiard G, Stavrinides V, Chambers ES, Heavey S, Freeman A, Ball R, Akbar AN, Emberton M.
    Nat Rev Urol; 2021 Oct; 18(10):597-610. PubMed ID: 34294916
    [Abstract] [Full Text] [Related]

  • 2. Progression of benign prostatic hyperplasia is associated with pro-inflammatory mediators and chronic activation of prostate-infiltrating lymphocytes.
    Norström MM, Rådestad E, Sundberg B, Mattsson J, Henningsohn L, Levitsky V, Uhlin M.
    Oncotarget; 2016 Apr 26; 7(17):23581-93. PubMed ID: 26993768
    [Abstract] [Full Text] [Related]

  • 3. Targetable mechanisms driving immunoevasion of persistent senescent cells link chemotherapy-resistant cancer to aging.
    Muñoz DP, Yannone SM, Daemen A, Sun Y, Vakar-Lopez F, Kawahara M, Freund AM, Rodier F, Wu JD, Desprez PY, Raulet DH, Nelson PS, van 't Veer LJ, Campisi J, Coppé JP.
    JCI Insight; 2019 Jun 11; 5(14):. PubMed ID: 31184599
    [Abstract] [Full Text] [Related]

  • 4. The senescence-associated secretory phenotype (SASP) from mesenchymal stromal cells impairs growth of immortalized prostate cells but has no effect on metastatic prostatic cancer cells.
    Alessio N, Aprile D, Squillaro T, Di Bernardo G, Finicelli M, Melone MA, Peluso G, Galderisi U.
    Aging (Albany NY); 2019 Aug 14; 11(15):5817-5828. PubMed ID: 31412320
    [Abstract] [Full Text] [Related]

  • 5. Expression of senescence-associated beta-galactosidase in enlarged prostates from men with benign prostatic hyperplasia.
    Choi J, Shendrik I, Peacocke M, Peehl D, Buttyan R, Ikeguchi EF, Katz AE, Benson MC.
    Urology; 2000 Jul 14; 56(1):160-6. PubMed ID: 10869659
    [Abstract] [Full Text] [Related]

  • 6. The senescence-associated secretory phenotype promotes benign prostatic hyperplasia.
    Vital P, Castro P, Tsang S, Ittmann M.
    Am J Pathol; 2014 Mar 14; 184(3):721-31. PubMed ID: 24434012
    [Abstract] [Full Text] [Related]

  • 7. JUN mediates the senescence associated secretory phenotype and immune cell recruitment to prevent prostate cancer progression.
    Redmer T, Raigel M, Sternberg C, Ziegler R, Probst C, Lindner D, Aufinger A, Limberger T, Trachtova K, Kodajova P, Högler S, Schlederer M, Stoiber S, Oberhuber M, Bolis M, Neubauer HA, Miranda S, Tomberger M, Harbusch NS, Garces de Los Fayos Alonso I, Sternberg F, Moriggl R, Theurillat JP, Tichy B, Bystry V, Persson JL, Mathas S, Aberger F, Strobl B, Pospisilova S, Merkel O, Egger G, Lagger S, Kenner L.
    Mol Cancer; 2024 May 29; 23(1):114. PubMed ID: 38811984
    [Abstract] [Full Text] [Related]

  • 8. Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer.
    Mori JO, Elhussin I, Brennen WN, Graham MK, Lotan TL, Yates CC, De Marzo AM, Denmeade SR, Yegnasubramanian S, Nelson WG, Denis GV, Platz EA, Meeker AK, Heaphy CM.
    Nat Rev Urol; 2024 May 29; 21(5):258-273. PubMed ID: 37907729
    [Abstract] [Full Text] [Related]

  • 9. Impact of Senescent Cell Subtypes on Tissue Dysfunction and Repair: Importance and Research Questions.
    Tripathi U, Misra A, Tchkonia T, Kirkland JL.
    Mech Ageing Dev; 2021 Sep 29; 198():111548. PubMed ID: 34352325
    [Abstract] [Full Text] [Related]

  • 10. Epithelial-mesenchymal transition in prostatic disease.
    Broster SA, Kyprianou N.
    Future Oncol; 2015 Sep 29; 11(23):3197-206. PubMed ID: 26551285
    [Abstract] [Full Text] [Related]

  • 11. [Chronic inflammation as promotor and treatment target in benign prostate hyperplasia (BPH) and in prostate cancer].
    Kramer G, Mitteregger D, Maj-Hes A, Sevchenco S, Brozek W.
    Urologe A; 2007 Sep 29; 46(9):1095-6. PubMed ID: 17671777
    [No Abstract] [Full Text] [Related]

  • 12. Senescent cells as a source of inflammatory factors for tumor progression.
    Davalos AR, Coppe JP, Campisi J, Desprez PY.
    Cancer Metastasis Rev; 2010 Jun 29; 29(2):273-83. PubMed ID: 20390322
    [Abstract] [Full Text] [Related]

  • 13. The putative contribution of cellular senescence to driving tauopathies.
    Karabag D, Heneka MT, Ising C.
    Trends Immunol; 2024 Oct 29; 45(10):837-848. PubMed ID: 39306559
    [Abstract] [Full Text] [Related]

  • 14. Mechanisms and Regulation of Cellular Senescence.
    Roger L, Tomas F, Gire V.
    Int J Mol Sci; 2021 Dec 06; 22(23):. PubMed ID: 34884978
    [Abstract] [Full Text] [Related]

  • 15. From Development to Aging: The Path to Cellular Senescence.
    Sacco A, Belloni L, Latella L.
    Antioxid Redox Signal; 2021 Feb 01; 34(4):294-307. PubMed ID: 32228062
    [Abstract] [Full Text] [Related]

  • 16. Elevated serum levels of p105(erbB-2) in patients with advanced-stage prostatic adenocarcinoma.
    Myers RB, Brown D, Oelschlager DK, Waterbor JW, Marshall ME, Srivastava S, Stockard CR, Urban DA, Grizzle WE.
    Int J Cancer; 1996 Oct 21; 69(5):398-402. PubMed ID: 8900374
    [Abstract] [Full Text] [Related]

  • 17. Atypical intraepithelial lesions of the prostate gland.
    Murphy WM.
    Am J Clin Pathol; 1991 Nov 21; 96(5):561-3. PubMed ID: 1719794
    [No Abstract] [Full Text] [Related]

  • 18. Macrophages and tumor-associated macrophages in the senescent microenvironment: From immunosuppressive TME to targeted tumor therapy.
    Du M, Sun L, Guo J, Lv H.
    Pharmacol Res; 2024 Jun 21; 204():107198. PubMed ID: 38692466
    [Abstract] [Full Text] [Related]

  • 19. [Benign mimickers of prostatic adenocarcinoma: diagnostic features and differential diagnosis].
    Cheng L, Huang W, Li Y, Wang L.
    Zhonghua Bing Li Xue Za Zhi; 2014 Jan 21; 43(1):52-8. PubMed ID: 24713255
    [No Abstract] [Full Text] [Related]

  • 20. Profiling molecular targets of TGF-beta1 in prostate fibroblast-to-myofibroblast transdifferentiation.
    Untergasser G, Gander R, Lilg C, Lepperdinger G, Plas E, Berger P.
    Mech Ageing Dev; 2005 Jan 21; 126(1):59-69. PubMed ID: 15610763
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.